These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 20331507

  • 1. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W, Shi J, Xie WF.
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [Abstract] [Full Text] [Related]

  • 2. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
    Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H.
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
    [Abstract] [Full Text] [Related]

  • 3. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L, Tian J, Liu P, Wang X, Zhu Z.
    Tumori; 2016 Jun 02; 2016(3):301-10. PubMed ID: 27002950
    [Abstract] [Full Text] [Related]

  • 4. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec 02; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 5. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group.
    Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097
    [Abstract] [Full Text] [Related]

  • 6. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
    Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM.
    Eur J Surg Oncol; 2005 May 01; 31(4):331-47. PubMed ID: 15837037
    [Abstract] [Full Text] [Related]

  • 7. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar 01; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 8. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS.
    Ai Zheng; 2005 Jul 01; 24(7):827-33. PubMed ID: 16004809
    [Abstract] [Full Text] [Related]

  • 9. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.
    Am Surg; 2002 Sep 01; 68(9):827-31. PubMed ID: 12356160
    [Abstract] [Full Text] [Related]

  • 10. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP, Rossi S, Deibert P, Zuber I, Hering M, Blum HE.
    Praxis (Bern 1994); 2000 Jun 15; 89(24):1056-60. PubMed ID: 10902462
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhang FJ, Wu PH, Zhao M, Gu YK, Zhang L, Tan ZB.
    Zhonghua Zhong Liu Za Zhi; 2005 Apr 15; 27(4):248-50. PubMed ID: 15949431
    [Abstract] [Full Text] [Related]

  • 12. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
    Georgiades CS, Hong K, Geschwind JF.
    Cancer J; 2008 Apr 15; 14(2):117-22. PubMed ID: 18391617
    [Abstract] [Full Text] [Related]

  • 13. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
    Yang P, Liang M, Zhang Y, Shen B.
    Adv Ther; 2008 Aug 15; 25(8):787-94. PubMed ID: 18670743
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 15. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH, Bruners P, Günther RW.
    Dig Dis; 2009 May 10; 27(2):148-56. PubMed ID: 19546553
    [Abstract] [Full Text] [Related]

  • 16. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
    Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C.
    Cancer; 2009 Nov 15; 115(22):5132-8. PubMed ID: 19672999
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.
    Korean J Hepatol; 2009 Dec 15; 15(4):474-85. PubMed ID: 20037266
    [Abstract] [Full Text] [Related]

  • 18. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.
    Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY.
    J Clin Oncol; 2013 Feb 01; 31(4):426-32. PubMed ID: 23269991
    [Abstract] [Full Text] [Related]

  • 19. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
    Huo T, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, Lee SD.
    Aliment Pharmacol Ther; 2004 Jun 15; 19(12):1301-8. PubMed ID: 15191512
    [Abstract] [Full Text] [Related]

  • 20. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK.
    Ai Zheng; 2004 Jul 15; 23(7):829-32. PubMed ID: 15248922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.